Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Letsure 5 Tablet

Prescription Icon
Prescription Required

Marketer

Astraea Life Sciences Pvt Ltd

Salt Composition

Letrozole (5mg)

Overview Letsure 5 Tablet

Postmenopausal women with breast cancer may find relief with Letsure 5 Tablet. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. Its application extends to advanced breast cancer, aiding in metastasis prevention. Letsure 5 Tablet can be ingested with or without food, always adhering to the physician's prescribed dosage and duration for optimal results. Dosage frequency varies based on the treatment goal, determined by your doctor to manage symptoms effectively. Continuous use is crucial, as directed by your physician. Common side effects include hot flushes, tiredness, excessive perspiration, and elevated cholesterol. Report any concerning or persistent side effects immediately. Your doctor can offer strategies for mitigation. Prior to initiating treatment, inform your doctor of any past liver or kidney issues, or pre-existing osteoporosis. Comprehensive disclosure of all other medications is vital, as interactions can affect Letsure 5 Tablet's efficacy. Pregnancy or breastfeeding must also be reported. Baseline and ongoing blood tests may be conducted to monitor vitamin D levels and bone density.

Uses of Letsure 5 Tablet

Managing breast cancer

Major Benefits of Letsure 5 Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letsure 5 Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Letsure 5 Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letsure 5 Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Letsure 5 Tablets can be consumed with or without food, although consistent timing is recommended.

How Letsure 5 Tablet works:

Letsure 5 Tablets function as an aromatase inhibitor, reducing the body's estrogen production. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letsure 5 Tablet can be taken with alcohol without adverse reactions.

PregnancyPregnancyUNSAFE

Using Letsure 5 Tablet during pregnancy is strongly discouraged due to substantial risks. Pregnant women should consult their physician; research in both animal and human studies indicates significant potential harm to the fetus.

Breast feedingBreast feedingUNSAFE

Administration of Letsure 5 Tablet is contraindicated while breastfeeding due to potential infant toxicity.

DrivingDrivingUNSAFE

Taking Letsure 5 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Renal impairment does not necessitate a dosage change for Letsure 5 Tablet, which is considered safe in such patients. Data regarding its use in end-stage renal disease is, however, scarce. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when prescribing Letsure 5 Tablet to patients exhibiting hepatic impairment; dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Letsure 5 Tablet :

Should you forget a Letsure 5 Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Letsure 5 Tablet

LabelValue
Pharmaceutical Category Benzophenone-related compound
Potential for Dependence None.
Medication Classification Cancer treatments

FAQs on Letsure 5 Tablet

Letsure 5 tablets function as an aromatase inhibitor, typically administered for breast cancer in postmenopausal women or those who have experienced amenorrhea following surgery or chemotherapy.
The medication Letsure 5 Tablet functions as an aromatase inhibitor, a class of anti-estrogenic drugs. Its mechanism involves suppressing estrogen synthesis by inhibiting the aromatase enzyme, crucial for estrogen production. Estrogen fuels the growth of certain breast cancers, termed "estrogen-receptor-positive" cancers. Decreasing estrogen levels can therefore hinder tumor progression.
For advanced breast cancer or cancer that has metastasized, Letsure 5 Tablet should be continued until tumor progression is observed. Following tamoxifen therapy or surgery, Letsure 5 Tablet is typically administered for five years or until recurrence, whichever occurs sooner. Alternatively, a sequential regimen of two years of Letsure 5 Tablet followed by three years of tamoxifen may be employed.
Concurrent use of irbesartan and Letsure 5 Tablet is permissible. Close monitoring of blood pressure is advised, as Letsure 5 Tablet can elevate blood pressure. Seek medical attention if blood pressure management proves difficult.
While rare, Letsure 5 Tablet use may be associated with cataract development. Therefore, blurred vision or eye discomfort warrants prompt medical attention.
Experiencing this may indicate hot flashes, a frequent side effect of Letsure 5 Tablet. This is often caused by reduced estrogen. These episodes typically lessen as your body adapts to Letsure 5 Tablet. Nevertheless, some individuals might experience them throughout treatment, subsiding only after several months post-treatment. For significant discomfort, seek guidance from your physician for appropriate management.
While rare, Letsure 5 Tablet may cause serious adverse events in a small percentage of users. These include stroke, angina, myocardial infarction, thromboembolic events, cataracts, osteoporosis, and severe dermatological reactions.
Letsure 5 Tablets can lead to bone thinning or loss (osteoporosis) resulting from reduced estrogen. Your physician might assess your bone density—a method for osteoporosis detection—before, throughout, and following treatment.
The Ministry of Health and Family Welfare designates Letsure 5 Tablet solely for ovulation induction in women with anovulatory infertility.
Letsure 5 Tablet
174
MRP 212
17% off